+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Matrix metalloproteinases and their inhibitors in tumor progression

Matrix metalloproteinases and their inhibitors in tumor progression

Annals of the new York Academy of Sciences 732: 222-232

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 032262637

Download citation: RISBibTeXText

PMID: 7978795

DOI: 10.1111/j.1749-6632.1994.tb24738.x

Related references

Matrix metalloproteinases and inhibitors Changing roles in tumor progression. FASEB Journal 15(5): A744, 2001

Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors. Journal of Oral Pathology and Medicine 44(6): 437-443, 2015

Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. Journal of Cancer Research and Clinical Oncology 129(2): 123-131, 2003

The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Turkish Journal of Gastroenterology 20(1): 41-47, 2009

Effects of Tumor Necrosis Factor Alpha on the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Keratoconus Fibroblasts. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 33(6): 1139-1144, 2016

Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Modern Pathology 19(4): 533-540, 2006

Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma. Digestive Diseases and Sciences 49(10): 1621-1630, 2004

Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues. Nihon Rinsho. Japanese Journal of Clinical Medicine 53(7): 1791-1797, 1995

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Seminars in Cancer Biology 20(3): 161-168, 2010

Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thrombosis Research 115(3): 205-210, 2005

Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneurysms. Annals of Vascular Surgery 26(3): 322-329, 2012

Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis. Journal of Endodontics 42(7): 1082-1088, 2016

Matrix metalloproteinases and tumor progression. Advances in Experimental Medicine and Biology 532: 91, 2003

Matrix metalloproteinases in tumor progression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 769-770, 1999

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Reviews 14(4): 351-362, 1995